Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

The Peds Obesity Study

15 juni 2018 uppdaterad av: University of Florida

Partial Meal Replacements Providing High Protein, Restricted Carbohydrates in the Treatment of Adolescents With Severe Obesity: A Randomized Controlled Trial

The aim of the study is to investigate, in severely obese adolescents, the effects of a high protein, restricted carbohydrates utilizing partial meal replacements diet (HPRC-PMR) on weight loss, body composition, and bio-chemical markers of lipid metabolism, insulin resistance, and inflammation over a 12 months period.

Studieöversikt

Status

Avslutad

Betingelser

Detaljerad beskrivning

Severely obese adolescents (13 to 17 year old males and post-menarcheal females between the ages of 12 and 17) will be recruited through the University of Florida Health Pediatric Weight Management Center. Therefore, all these patients would have undergone a multifaceted assessment that is part of the standard of care at the University of Florida Pediatric Weight Management Center. This includes a behavioral assessment conducted by the Center's psychologist, a detailed medical history and physical examination as well as a comprehensive laboratory testing to investigate for obesity comorbidities as indicated clinically for the individual patient. These laboratory tests include but not limited to the following: Complete Blood Count, comprehensive metabolic panel, liver enzymes, thyrotropin, fasting plasma glucose and insulin levels, fasting lipid profile and urinalysis. In addition, as part of the standard of care at the University of Florida Pediatric Weight Management Center, patients and families complete the Obesity and Quality of Life questionnaires as well as the University of Florida Pediatric Weight Management Center Physical Activity questionnaire. Inclusion criteria include adolescents with primary obesity and a BMI≥ 99th percentile for age. Exclusion criteria include current diagnosis of Type II Diabetes Mellitus; gall bladder, liver or renal disorders; known eating disorders; known endocrine disorders such as hypothyroidism or polycystic ovary syndrome; pregnancy; genetic disorder, such as Prader-Willi Syndrome; mental retardation; severe depression; or use of any chronic medication that could impact appetite significantly. Patients with poor family support that might potentially preclude compliance with the study requirements will also be excluded. These diseases will be ruled out by means of medical history, physical examination and standard of care laboratory tests obtained on patients upon their entry to the University of Florida Health Pediatric Weight Management Center. A urine pregnancy test will be performed on female adolescents prior to enrolment in the study. Written informed consent will be obtained from the parent and assent from the adolescent.

These patients will participate in a high protein, restricted carbohydrates utilizing partial meal replacements diet (HPRC-PMR) after obtaining consent to participate in the study.

Behavioral counseling will be provided to all participants in the study. The behavior modification used as part of the standard of care at the University of Florida Health Pediatric Weight Management Center includes a combination of immediate, short-term, and long-term individual and family psychotherapy sessions to increase motivation to change diet and physical activity level. These treatments may also help children cope with the emotional stresses associated with being overweight and boost confidence especially within the school system. Obesity and Quality of Life survey will be completed by patients at baseline, and at 3, 6 and 12 months after enrollment. (Permission to use this survey in the Center was obtained from Obesity and Quality of Life Consulting, Durham, North Carolina, and Children's Hospital Medical Center, OH). The survey includes questions regarding physical comfort, body esteem, social life and family relations.

Patients on the HPRC-PMR diet will follow 4 phases. Please see attached table for details.

The minimum amount of protein intake should be 1 g/Kg of protein/day. All meats and fish are permitted in this phase. Lean meats should be chosen. Patients will be encouraged to avoid hunger by having meals and 3 snacks throughout the day.

Enrolled participants will have scheduled meetings with the dietitian. The schedule involves weekly meetings for the first 2 months, then every other week for additional 4 months, followed by monthly meeting for additional 6 months for each patient/family.

Participants will be encouraged via the scheduled meetings with the dietitian to manage expected slip-ups. Minor, inconsequential slip-ups usually occur when the patient is not eating at home. In these cases, patients are encouraged to avoid carbohydrates, or starchy foods and desserts. In these cases, there will be no consequences, as long as these meals don't become a habit should go back to their regular diet the next day. A major diet slip-up is a big meal with all the trimmings. Patient will be encouraged to make up for a major diet slip-up the next day by avoiding all simple and complex carbohydrates for that one day only.

All participants will be encouraged to have "break day" in the maintenance phase. It is a day where the patient goes "all-out" and enjoys whatever foods they feel like eating! Dieters who have struggled with his/her weight and beef, poultry, pork or veal in place of the meal replacement at lunch.

Studietyp

Interventionell

Inskrivning (Faktisk)

12

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Florida
      • Jacksonville, Florida, Förenta staterna, 32207
        • University of Florida Pediatric Weight Management Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

12 år till 17 år (Barn)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Severely obese adolescents (13 to 17 year old males and post-menarcheal females between the ages of 12 and 17) will be recruited through the UF Health Pediatric Weight Management Center.
  • All patients would undergo a multifaceted assessment that is part of the standard of care at the UF Pediatric Weight Management Center. (This includes a behavioral assessment conducted by the Center's psychologist, a detailed medical history and physical examination as well as a comprehensive laboratory testing to investigate for obesity comorbidities as indicated clinically for the individual patient. These laboratory tests include but not limited to the following: CBC, comprehensive metabolic panel, liver enzymes, thyrotropin, fasting plasma glucose and insulin levels, fasting lipid profile and urinalysis.)
  • As part of the standard of care at the UF Pediatric Weight Management Center, patients and families complete the IWQOL (Obesity and Quality of Life) questionnaires as well as the UF Pediatric Weight Management Center Physical Activity questionnaire.
  • Adolescents with primary obesity and a BMI≥ 99th percentile for age.

Exclusion Criteria:

  • Current Diagnosis of Type II Diabetes Mellitis
  • Gall Bladder, Renal or Liver Disorders
  • Known Eating Disorders
  • Known Endocrine Disorders (such as hyperthyroidism or polycystic ovary syndrome)
  • Pregnancy
  • Genetic disorder (such as Prader-Willi Syndrome)
  • Mental Retardation
  • Severe Depression
  • Use of any chronic medicine which could impact appetite

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Grundläggande vetenskap
  • Tilldelning: Icke-randomiserad
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Male High Protein, Restricted Carbo, Partial Meal Replacement
A high protein, restricted carbohydrates diet that utilizes partial meal replacements
The use of partial meal replacements will be utilized in conjunction with a high protein, restricted carbohydrate diet
Aktiv komparator: Female High Protein, Restricted Carbo, Partial Meal Replaceme
A high protein, restricted carbohydrates diet that utilizes partial meal replacements
The use of partial meal replacements will be utilized in conjunction with a high protein, restricted carbohydrate diet

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Improvement in BMI-Z Scores
Tidsram: 12 months
BMI measurements will be taken at all appointments for 12 months to track improvement in BMI
12 months
Weight Loss
Tidsram: 12 months
Weigh will be obtained at each appointment to track weight loss of 12 months
12 months
Metabolic Abnormalities (Periodic labwork will be obtained over the 12 month period to monitor metabolic abnormalities)
Tidsram: 12 months
Periodic labwork will be obtained over the 12 month period to monitor metabolic abnormalities
12 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Samarbetspartners

Utredare

  • Huvudutredare: Madeline Joseph, MD, UFJP

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 november 2014

Primärt slutförande (Faktisk)

22 februari 2018

Avslutad studie (Faktisk)

22 februari 2018

Studieregistreringsdatum

Först inskickad

21 januari 2015

Först inskickad som uppfyllde QC-kriterierna

2 februari 2015

Första postat (Uppskatta)

3 februari 2015

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

19 juni 2018

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

15 juni 2018

Senast verifierad

1 juni 2018

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • UFJ 2014-140
  • IRB201702423 (Annan identifierare: University of Florida)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera